Skip to content

Calculus VCT

Open for 23/34 tax year

Next allotment: June 2023

What are VCTs?

VCTs were introduced in 1995 to encourage individuals to invest indirectly into small and growing UK trading companies, by offering a range of tax reliefs.

VCTs are listed on the London Stock Exchange. Investors are shareholders in a listed company overseen by an independent board and run by an investment manager, which in the case of Calculus VCT is Calculus Capital Ltd.

To qualify, at least 80% of a VCT’s investments must be in small, qualifying companies (with maximum gross assets of size £15 million) that are unquoted or traded on AIM.

Money raised from individual investors is used to acquire a number of different investments with the aim of spreading risk across the VCT portfolio. The Calculus VCT is targeting around 50 small UK companies across a diverse range of different sectors. The Calculus VCT provides immediate exposure to a diversified portfolio of entrepreneurial UK smaller companies with high growth potential. The additional funds will be used to provide development and scale-up capital to new investments with robust business models and to help drive growth in existing portfolio companies.

Calculus VCT – Key Features

  • Minimum Investment Amount – £5,000
  • Next allotment date – June 2023
  • Target dividend – 4.5% of NAV

Calculus VCT


Calculus VCT


Calculus VCT


Calculus VCT

Key Information Document

  • 30% income tax relief *
  • Capital gains on VCT shares are tax-free
  • Tax-free dividends **

* Shares have to be held for at least 5 years to benefit from Income Tax relief.

** It should be noted that there is no guarantee of dividend levels nor preservation of capital value.

We invest in entrepreneurial businesses with growth potential, across the fastest growing sectors in the UK. The portfolio will be focused around the following:


The UK is Europe’s number one technology nation, with tech VC investment third in the world, only behind the USA and China. This is largely due to world-class universities, a flexible labour market and investor capital supported by schemes such as EIS.

This hotbed of entrepreneurial activity and innovation presents a strong investment opportunity.

Within technology we predominantly look for companies providing software as a service (SaaS) to an already established client base.


The UK is in a good position to continue as world leaders in healthcare companies. With top universities, government R&D spend, charitable support and our National Health Service which is a unique institution, the sector is thriving and making significant input into worldwide development.

Within the healthcare sector we will predominantly look for companies within diagnostics, pharmaceutical services and drug discovery.


The UK is a global force in creating content for the screen industries, with world-class infrastructure and talent. UK creative content companies have an established track record of producing award winning, commercially successful films and television shows watched by millions worldwide and are ideally placed to benefit from this growth in content expenditure.

Please take the time to read through the Key Risks

Please click here to view our Calculus VCT Investor Information page for more information on AGM Results, annual reports and more.

Find out more

We would be delighted to answer any queries you have. Please contact the Sales and Marketing team on 020 7493 4940.

Madeleine Ingram - Co-Head, Sales & Marketing – Calculus

Madeleine Ingram

Co-Head, Sales & Marketing

Francesca Rayneau - Co-Head, Sales & Marketing – Calculus

Francesca Rayneau

Co-Head, Sales & Marketing

Matthew Moynes - Sales & Marketing – Calculus

Matthew Moynes

Sales & Marketing

Oliver Warren - Sales & Marketing – Calculus

Oliver Warren

Sales & Marketing

Frank Spurway - Sales & Marketing – Calculus

Frank Spurway

Sales & Marketing